The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
|Articles|March 28, 2012
Next Pharmaceuticals Reintroduces Relora
Next Pharmaceuticals has redesigned its website for Relora, a stress-relief dietary supplement named one of Dr. Oz’s top “belly-blasting supplements.”
Advertisement
Next Pharmaceuticals (Salinas, CA) has redesigned its website for Relora, a
Relora’s new website is intended for easy communication of the ingredient’s benefits from practitioners and retailers to consumers.
Advertisement
Related to this article
Women are the predominant users of these drugs, and the authors say guidance has not kept pace, with nutrient gaps and supplement support also in focus.
Trade groups say the law's broad criteria could restrict access to supplements with uses beyond weight loss or muscle building.
At The Outlook on Active Nutrition, Doug Kalman, PhD, RD, FISSN, outlines where GLP-1 drugs are falling short, and where nutraceutical brands can step in.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Omega-3 Supply, Not Price, Is the Real Threat
2
Beyond Protein: How Fiber, Gut Health, and Format Are Reshaping Snack Bars in 2026
3
FDA’s Proposed GRAS Rule, and What Industry Should Do Now
4
Clean Form Nutrition Earns NSF Certified for Sport for Product Made With NNB’s Pürest Creatine
5